title: Recent progress on targeting the αvβ1 integrin for the treatment of tissue fibrosis.
authors.affiliation: a MRC Centre for Inflammation Research , Queens Medical Research Institute , Edinburgh , UK.
authors.forename: James R
authors.initials: JR
authors.lastname: Smith
authors.affiliation: a MRC Centre for Inflammation Research , Queens Medical Research Institute , Edinburgh , UK.
authors.forename: Neil C
authors.initials: NC
authors.lastname: Henderson
mesh_terms: D000818:Animals; D015195:Drug Design; D005109:Extracellular Matrix / Q000378:metabolism; D005355:Fibrosis / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D019030:Receptors, Vitronectin / Q000378:metabolism*
chemical_list: D019030:Receptors, Vitronectin; C094340:integrin alphavbeta1
keywords: fibrosis; integrin; myofibroblast; small-molecule inhibition; αvβ1